Clinical trials represent the most expensive, recourse- and time-absorbing component of the whole drug development procedure. Operations within the biopharmaceutical field involve a wide variety of separate operations that include researching, collecting, estimating, systematizing and rationalizing data from a huge volume of sources. In order to ensure efficient Good Clinical Practices (GCPs), regulators urge sponsor organizations to provide a whole-system approach. Such approach will guarantee the well-being of patients and will also serve to orchestrate administrative and operational processes in...MORE >